Multidrug-resistant tuberculosis in Victoria: A 10-year review

Medical Journal of Australia

Volumn 191, Issue 6, 2009, Pages 315-318

  Lavender, Caroline J ^a   Brown, Lynne K ^b   Johnson, Paul D R ^c  

^a VICTORIAN INFECTIOUS DISEASES REFERENCE LABORATORY   (Australia)

^b Department of Health Victoria   (Australia)

^c AUSTIN HEALTH   (Australia)

Author keywords

[No Author keywords available]

Indexed keywords

ACID FAST BACTERIUM; ARTICLE; AUSTRALIA; DEMOGRAPHY; GROUPS BY AGE; HUMAN; LUNG DISEASE; MOLECULAR TYPING; MULTIDRUG RESISTANT TUBERCULOSIS; SPUTUM SMEAR; TREATMENT DURATION;

EID: 77952307454     PISSN: 0025729X     EISSN: 13265377     Source Type: Journal    
DOI: 10.5694/j.1326-5377.2009.tb02814.x     Document Type: Article

References (15)

1. National Tuberculosis Advisory Committee. Multi-drug resistant tuberculosis: information paper (October 2007). Commun Dis Intell 2007; 31: 406-409.
2. World Health Organization. Anti-tuberculosis drug resistance in the world: fourth global repor t . Geneva: WHO, 2008. http://www.who.int/tb/publ ications/2008/drs-report4-26feb08.pdf (accessed Mar 2008).
3. Lumb R, Bastian I, Gilpin C, et al. Tuberculosis in Australia: bacteriologically confirmed cases and drug resistance, 2006: a report of the Australian Mycobacterium Reference Laboratory Network. Commun Dis Intell 2008; 32: 12-17.
4. Victorian Government Department of Human Services. Management, control and prevention of tuberculosis: guidelines for health care providers. Melbourne: DHS, 2002.
5. Australian Education International. International student enrolments in Australia - 1994 to 2006. Canberra: AEI, 2008. http://aei.dest.gov.au/AEI/MIP/ Statistics/StudentEnrolmentAndVisaStatistics/2006/2006Annual- Stats.htm#1994 (accessed Sep 2008).
6. Australian Government Department of Immigration and Citizenship. Settler arrivals 1996-1997 to 2006-07 - Australia, states and territories. Canberra: DIAC, 2007.
7. Australian Government Department of Immigration and Citizenship. Supplement to form 1163i. Complete country listings for the health assessment matrix. Canberra: Commonwealth of Australia, 2009. http://www.immi.gov.au/ allforms/health-requirements/1163i-supplement.pdf (accessed Aug 2009).
8. White VL, Moore-Gillon J. Resource implications of patients with multidrug resistant tuberculosis. Thorax 2000; 55: 962-963.
9. Brown H. WHO identifies drug-resistant tuberculosis "hotspots". Lancet 2004; 363: 951.
10. Moore-Gillon J. Multidrug-resistant tuberculosis: this is the cost. Ann N Y Acad Sci 2001; 953: 233-240.
11. Menzies D. Screening immigrants to Canada for tuberculosis: chest radiography or tuberculin skin testing? CMAJ 2003; 169: 1035-1036. (Pubitemid 37449353)
12. Khan K, Muennig P, Behta M, Zivin JG. Global drug-resistance patterns and the management of latent tuberculosis infection in immigrants to the United States. N Engl J Med 2002; 347: 1850-1859. (Pubitemid 35417777)
13. Schwartzman K, Menzies D. Tuberculosis screening of immigrants to low-prevalence countries. A cost-effectiveness analysis. Am J Respir Crit Care Med 2000; 161: 780-789. (Pubitemid 30171731)
14. Coker R, van Weezenbeek KL. Mandatory screening and treatment of immigrants for latent tuberculosis in the USA: just restraint? Lancet Infect Dis 2001; 1: 270-276. (Pubitemid 33586059)
15. Broekmans JF, Migliori GB, Rieder HL, et al. European framework for tuberculosis control and elimination in countries with a low incidence. Recommendations of the World Health Organization (WHO), International Union Against Tuberculosis and Lung Disease (IUATLD) and Royal Netherlands Tuberculosis Association (KNCV) Working Group. Eur Respir J 2002; 19: 765-775.